Attenuated innate immunity in embryonic stem cells and its implications in developmental biology and regenerative medicine

Stem Cells

Volumn 33, Issue 11, 2015, Pages 3165-3173

  Guo, Yan Lin ^a   Carmichael, Gordon G ^b   Wang, Ruoxing ^a   Hong, Xiaoxiao ^b   Acharya, Dhiraj ^a   Huang, Faqing ^a   Bai, Fengwei ^a  

^a University of Southern Mississippi   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Antiviral response; Embryonic stem cells; Innate immunity; Regenerative medicine; Type I interferons

Indexed keywords

INTERFERON; MESSENGER RNA;

ADAPTIVE IMMUNITY; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL RENEWAL; CELLULAR IMMUNITY; CYTOKINE RESPONSE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DEVELOPMENTAL BIOLOGY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; IMMUNOBIOLOGY; IMMUNOGENICITY; IMMUNOSURVEILLANCE; INNATE IMMUNITY; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; REGENERATIVE MEDICINE; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; VIRUS INFECTION; ANIMAL; IMMUNOLOGY; PLURIPOTENT STEM CELL; TRENDS;

ANIMALS; CELL DIFFERENTIATION; DEVELOPMENTAL BIOLOGY; EMBRYONIC STEM CELLS; HUMANS; IMMUNITY, INNATE; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

EID: 84945476092     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2079     Document Type: Article

References (96)

1. Wobus AM, Boheler KR,. Embryonic stem cells: Prospects for developmental biology and cell therapy. Physiol Rev 2005; 85: 635-678.
2. Murry CE, Keller G,. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell 2008; 132: 661-680.
3. Foldes G, Liu A, Badiger R, et al., Innate immunity in human embryonic stem cells: Comparison with adult human endothelial cells. PLoS One 2010; 5: e10501.
4. Zampetaki A, Xiao Q, Zeng L, et al., TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modifications. Biochem Biophys Res Commun 2006; 347: 89-99.
5. Glaser DE, Gower RM, Lauer NE, et al., Functional characterization of embryonic stem cell-derived endothelial cells. J Vasc Res 2011; 48: 415-428.
6. Rajan R, Ye J, Bai S, et al., NF-κB, but not p38 MAP Kinase, is required for TNF-α-induced expression of cell adhesion molecules in endothelial cells. J Cell Biochem 2008; 105: 477-486.
7. Samuel CE,. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14: 778-809.
8. Stetson DB, Medzhitov R,. Type I interferons in host defense. Immunity 2006; 25: 373-381.
9. Sen GC,. Virues and infections. Annu Rev Microbiol 2001; 55: 255-281.
10. Swartzendruber DE, Lehman JM,. Neoplastic differentiation: Interaction of simian virus 40 and polyoma virus with murine teratocarcinoma cells in vitro. J Cell Physiol 1975; 85: 179-187.
11. Swartzendruber DE, Friedrich TD, Lehman JM,. Resistance of teratocarcinoma stem cells to infection with simian virus 40: Early events. J Cell Physiol 1977; 93: 25-30.
12. Burke DC, Graham CF, Lehman JM,. Appearance of interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro. Cell 1978; 13: 243-248.
13. Yang S, Tutton S, Pierce E, et al., Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol Cell Biol 2001; 21: 7807-7816.
14. Yu J, Rossi R, Hale C, et al., Interaction of enteric bacterial pathogens with murine embryonic stem cells. Infect Immunity 2009; 77: 585-597.
15. Taylor T, Kim YJ, Ou X, et al., Toll-like receptor 2 mediates proliferation, survival, NF-kappaB translocation, and cytokine mRNA expression in LIF-maintained mouse embryonic stem cells. Stem Cells Dev 2010; 19: 1333-1341.
16. Chen GY, Hwang SM, Su HJ, et al., Defective antiviral responses of induced pluripotent stem cells to baculoviral vector transduction. J Virol 2012; 86: 8041-8049.
17. Chen LL, Yang L, Carmichael GG,. Molecular basis for an attenuated cytoplasmic dsRNA response in human embryonic stem cells. Cell Cycle 2010; 9: 3552-3564.
18. English K, Wood KJ,. Immunogenicity of embryonic stem cell-derived progenitors after transplantation. Curr Opin Organ Transplant 2011; 16: 90-95.
19. de Almeida PE, Ransohoff JD, Nahid A, et al., Immunogenicity of pluripotent stem cells and their derivatives. Circ Res 2013; 112: 549-561.
20. Tan Y, Ooi S, Wang L,. Immunogenicity and tumorigenicity of pluripotent stem cells and their derivatives: Genetic and epigenetic perspectives. Curr Stem Cell Res Ther 2014; 9: 63-72.
21. Boyd AS, Higashi Y, Wood KJ,. Transplanting stem cells: Potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation. Adv Drug Deliv Rev 2005; 57: 1944-1969.
22. Drukker M, Katz G, Urbach A, et al., Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 2002; 99: 9864-9869.
23. Magliocca JF, Held IKA, Odorico JS,. Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. Stem Cells Dev 2006; 15: 707-717.
24. Li L, Baroja ML, Majumdar A, et al., Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004; 22: 448-456.
25. Kimbrel EA, Kouris NA, Yavanian GJ, et al., Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev 2014; 23: 1611-1624.
26. Bonde S, Chan KM, Zavazava N,. ES-cell derived hematopoietic cells induce transplantation tolerance. PLoS One 2008; 3: e3212.
27. Swijnenburg RJ, Tanaka M, Vogel H, et al., Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 2005; 112: I-166.
28. Boyd AS, Wood KJ,. Variation in MHC expression between undifferentiated mouse ES cells and ES cell derived insulin-producing cell clusters. Transplantation 2009; 87: 1300-1304.
29. Ma M, Ding S, Lundqvist A, et al., Major histocompatibility complex-I expression on embryonic stem cell-derived vascular progenitor cells is critical for syngeneic transplant survival. Stem Cells 2010; 28: 1465-1475.
30. Suarez-Alvarez B, Rodriguez RnM, Calvanese V, et al., Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells. PLoS One 2010; 5: e10192.
31. Peterson SE, Loring JF,. Genomic instability in pluripotent stem cells: Implications for clinical applications. J Biol Chem 2014; 289: 4578-4584.
32. Fu X,. The immunogenicity of cells derived from induced pluripotent stem cells. Cell Mol Immunol 2014; 11: 14-16.
33. Keller G,. Embryonic stem cell differentiation: Emergence of a new era in biology and medicine. Genes Dev 2005; 19: 1129-1155.
34. Mai J, Virtue A, Shen J, et al., An evolving new paradigm: Endothelial cells-Conditional innate immune cells. J Hematol Oncol 2013; 6: 61.
35. Bell E,. Innate immunity: Endothelial cells as sentinels. Nat Rev Immunol 2009; 9: 532-533.
36. Zampetaki A, Zeng L, Xiao Q, et al., Lacking cytokine production in ES cells and ES-cell-derived vascular cells stimulated by TNF-alpha is rescued by HDAC inhibitor trichostatin A. Am J Physiol Cell Physiol 2007; 293: C1226-C1238.
37. Sidney LE, Kirkham GR, Buttery LD,. Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL-1beta, TNF-alpha, and IFN-gamma. Stem Cells Dev 2014; 23: 605-617.
38. Yeung ATY, Hale C, Xia J, et al., Conditional-ready mouse embryonic stem cell derived macrophages enable the study of essential genes in macrophage function. Sci Rep 2015; 5: 8908.
39. Rossi R, Hale C, Goulding D, et al., Interaction of Salmonella typhimurium with dendritic cells derived from pluripotent embryonic stem cells. PLoS One 2012; 7: e52232.
40. Karlsson KR, Cowley S, Martinez FO, et al., Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3. Exp Hematol 2008; 36: 1167-1175.
41. Subramanian A, Guo B, Marsden MD, et al., Macrophage differentiation from embryoid bodies derived from human embryonic stem cells. J Stem Cells 2009; 4: 29-45.
42. Moore KJ, Fabunmi RP, Andersson LP, et al., In Vitro differentiated embryonic stem cell macrophages: A model system for studying atherosclerosis-associated macrophage functions. Arterioscler Thromb Vasc Biol 1998; 18: 1647-1654.
43. Knorr DA, Ni Z, Hermanson D, et al., Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy. Stem Cells Translational Med 2013; 2: 274-283.
44. Knorr DA, Kaufman DS,. Pluripotent stem cell-derived natural killer cells for cancer therapy. Translational Res 2010; 156: 147-154.
45. Woll PS, Martin CH, Miller JS, et al., Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity. J Immunol 2005; 175: 5095-5103.
46. Yamashita J, Itoh H, Hirashima M, et al., Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000; 408: 92-96.
47. Levenberg S, Golub JS, Amit M, et al., Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2002; 99: 4391-4396.
48. McCloskey KE, Stice SL, Nerem RM,. In vitro derivation and expansion of endothelial cells from embryonic stem cells. Methods Mol Biol 2006; 330: 287-301.
49. Blancas AA, Lauer NE, McCloskey KE,. Endothelial differentiation of embryonic stem cells. Curr Protoc Stem Cell Biol 2008; 6: 1F.5.1-1F.5.19.
50. Sinha S, Hoofnagle MH, Kingston PA, et al., Transforming growth factor-{beta}1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol 2004; 287: C1560-C1568.
51. Kawai T, Akira S,. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34: 637-650.
52. Yoneyama M, Kikuchi M, Natsukawa T, et al., The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5: 730-737.
53. Garcia MA, Meurs EF, Esteban M,. The dsRNA protein kinase PKR: Virus and cell control. Biochimie 2007; 89: 799-811.
54. Freudenberg MA, Tchaptchet S, Keck S, et al., Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: Benefits and hazards of LPS hypersensitivity. Immunobiology 2008; 213: 193-203.
55. Matsumoto M, Seya T,. TLR3: Interferon induction by double-stranded RNA including poly(I:C). Adv Drug Deliv Rev 2008; 60: 805-812.
56. Lee SH, Hong B, Sharabi A, et al., Embryonic stem cells and mammary luminal progenitors directly sense and respond to microbial products. Stem Cells 2009; 27: 1604-1615.
57. Wash R, Calabressi S, Franz S, et al., Permissive and restricted virus infection of murine embryonic stem cells. J Gen Virol 2012; 93: 2118-2130.
58. Wang R, Wang J, Paul AM, et al., Mouse embryonic stem cells are deficient in type I interferon expression in response to viral infections and double-stranded RNA. J Biol Chem 2013; 288: 15926-15936.
59. Wang R, Teng C, Spangler J, et al., Mouse embryonic stem cells have underdeveloped antiviral mechanisms that can be exploited for the development of mRNA-mediated gene expression strategy. Stem Cells Dev 2014; 23: 594-604.
60. Gonzalez-Navajas JM, Lee J, David M, et al., Immunomodulatory functions of type I interferons. Nat Rev Immunol 2012; 12: 125-135.
61. Hong XX, Carmichael GG,. Innate immunity in pluripotent human cells: Attenuated response to interferon-β. J Biol Chem 2013; 288: 16196-16205.
62. Kubo M, Hanada T, Yoshimura A,. Suppressors of cytokine signaling and immunity. Nat Immunol 2003; 4: 1169-1176.
63. Hertzog PJ, Hwang SY, Kola I,. Role of interferons in the regulation of cell proliferation, differentiation, and development. Mol Reprod Dev 1994; 39: 226-232.
64. Dumitru R, Gama V, Fagan B, et al., Human embryonic stem cells have constitutively active bax at the golgi and are primed to undergo rapid apoptosis. Mol Cell 2012; 46: 573-583.
65. Whyatt LM, Duwel A, Smith AG, et al., The responsiveness of embryonic stem cells to alpha and beta interferons provides the basis of an inducible expression system for analysis of developmental control genes. Mol Cell Biol 1993; 13: 7971-7976.
66. Ruffner H, Reis LF, Naf D, et al., Induction of type I interferon genes and interferon-inducible genes in embryonal stem cells devoid of interferon regulatory factor 1. Proc Natl Acad Sci USA 1993; 90: 11503-11507.
67. Wang R, Wang J, Acharya D, et al., Antiviral responses in mouse embryonic stem cells: Differential development of cellular mechanisms in type I interferon production and response. J Biol Chem 2014; 289: 25186-25198.
68. Chen LL, DeCerbo JN, Carmichael GG,. Alu element-mediated gene silencing. EMBO J 2008; 27: 1694-1705.
69. Chen LL, Carmichael GG,. Altered nuclear retention of mrnas containing inverted repeats in human embryonic stem cells: Functional role of a nuclear noncoding RNA. Mol Cell 2009; 35: 467-478.
70. Ginis I, Luo Y, Miura T, et al., Differences between human and mouse embryonic stem cells. Dev Biol 2004; 269: 360-380.
71. Matsuda T, Nakamura T, Nakao K, et al., STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J 1999; 18: 4261-4269.
72. Humphrey RK, Beattie GM, Lopez AD, et al., Maintenance of pluripotency in human embryonic stem cells is STAT3 Independent. Stem Cells 2004; 22: 522-530.
73. Burdon T, Smith A, Savatier P,. Signalling, cell cycle and pluripotency in embryonic stem cells. Trend Cell Biol 2002; 12: 432-438.
74. Dalton S,. Exposing hidden dimensions of embryonic stem cell cycle control. Cell Stem Cell 2009; 4: 9-10.
75. Levy O,. Innate immunity of the newborn: Basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7: 379-390.
76. Maillard PV, Ciaudo C, Marchais A, et al., Antiviral RNA interference in mammalian cells. Science 2013; 342: 235-238.
77. Fire A, Xu S, Montgomery MK, et al., Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811.
78. Pare JM, Sullivan CS,. Distinct antiviral responses in pluripotent versus differentiated cells. PLoS Pathog 2014; 10: e1003865.
79. Cullen BR, Cherry S, tenOever BR,. Is RNA interference a physiologically relevant innate antiviral immune response in mammals? Cell Host Microbe 2013; 14: 374-378.
80. Li Y, Lu J, Han Y, et al., RNA interference functions as an antiviral immunity mechanism in mammals. Science 2013; 342: 231-234.
81. Backes S, Langlois R, Schmid S, et al., The mammalian response to virus infection is independent of small RNA silencing. Cell Rep 2014; 8: 114-125.
82. Amarante MK, Watanabe MAE,. Toll-like receptor 3: Involvement with exogenous and endogenous RNA. Int Rev Immunol 2010; 29: 557-573.
83. Yu L, Wang L, Chen S,. Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med 2010; 14: 2592-2603.
84. Williams BR,. PKR; a sentinel kinase for cellular stress. Oncogene 1999; 18: 6112-6120.
85. Kim Y, Lee JH, Park JE, et al., PKR is activated by cellular dsRNAs during mitosis and acts as a mitotic regulator. Genes Dev 2014; 28: 1310-1322.
86. Takahashi K, Yamanaka S,. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
87. Buganim Y, Faddah DA, Jaenisch R,. Mechanisms and models of somatic cell reprogramming. Nat Rev Genet 2013; 14: 427-439.
88. Muller LU, Daley GQ, Williams DA,. Upping the ante: Recent advances in direct reprogramming. Mol Ther 2009; 17: 947-953.
89. Daubman S,. Landmark approach to generating human stem cells. Circ Res 2011; 108: 161-163.
90. Warren L, Manos PD, Ahfeldt T, et al., Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7: 618-630.
91. Yakubov E, Rechavi G, Rozenblatt S, et al., Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochem Biophys Res Commun 2010; 394: 189-193.
92. Plews JR, Li J, Jones M, et al., Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach. PLoS One 2010; 5: e14397.
93. Angel M, Yanik MF,. Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS One 2010; 5: e11756.
94. Huang F,. Efficient incorporation of CoA, NAD and FAD into RNA by in vitro transcription. Nucleic Acids Res 2003; 31: e8.
95. Ginsberg M, James D, Ding BS, et al., Efficient direct reprogramming of mature amniotic cells into endothelial cells by ets factors and TGF-beta suppression. Cell 2012; 151: 559-575.
96. Niwa H,. How is pluripotency determined and maintained? Development 2007; 134: 635-646.